查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1763150

全球自動免疫檢測設備市場

Automated Immunoassay Analyzers
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球自動免疫檢測設備市場規模將達 47 億美元

全球自動化免疫檢測設備市場規模預計在2024年為36億美元，預計到2030年將達到47億美元，2024年至2030年的複合年成長率為4.5% 。螢光是本報告分析的細分市場之一，預計其複合年成長率為4.7%，到分析期結束時規模將達到12億美元。化學冷光免疫檢測測定 (CLIA) 細分市場在分析期間的複合年成長率預計為4.3%。

美國市場規模估計為 9.933 億美元，中國市場預期複合年成長率為 4.4%

美國自動化免疫檢測市場規模預計在2024年達到9.933億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到7.544億美元，在2024-2030年的分析期間內，複合年成長率為4.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.2%和3.7%。在歐洲，預計德國市場的複合年成長率為4.4%。

全球自動免疫檢測儀器市場—主要趨勢與促進因素摘要

為什麼自動免疫檢測設備對於現代診斷至關重要？

自動化免疫檢測設備能夠快速、準確、高通量地檢測生物樣本，從而徹底革新診斷實驗室。這些儀器對於檢測和定量血液及其他體液中的特定蛋白質、荷爾蒙和抗體至關重要，在感染疾病診斷、腫瘤學和內分泌學等領域中發揮重要作用。隨著醫療保健系統重視早期檢測和個人化醫療，免疫測量已成為診斷愛滋病毒、癌症、糖尿病等疾病的重要工具。這些檢測的自動化不僅降低了人為錯誤的風險，還提高了診斷實驗室的效率，使其能夠以最少的人工處理大量樣本。隨著全球對診斷檢測需求的不斷成長，自動化免疫檢測設備正成為現代醫療保健的重要組成部分。

科技進步如何增強自動免疫檢測設備？

技術創新顯著提升了自動化免疫檢測儀器的功能和準確性。化學冷光和螢光等檢測方法的進步提高了靈敏度和特異性，從而能夠更快、更準確地檢測生物標記。此外，人工智慧 (AI) 和機器學習演算法正在整合到這些系統中，以最佳化複雜數據的分析和解讀，幫助臨床醫生做出更明智的診斷決策。自動化也延伸到了樣品製備和數據管理領域，進一步簡化了工作流程，縮短了獲得結果的時間。隨著實驗室尋求縮短週轉時間和提高業務效率，這些技術進步正在推動自動化免疫檢測儀器的廣泛應用。

哪些法規和合規標準管理自動免疫檢測設備的使用？

監管監督在自動化免疫檢測市場中至關重要，因為診斷測試的準確性和可靠性直接影響患者的治療。美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等機構執行嚴格的指導方針，以確保免疫檢測分析分析儀在上市前符合安全性和有效性標準。這些法規要求製造商進行嚴格的臨床試驗，並在生產過程中保持品管。此外，對於使用這些系統的實驗室來說，遵守ISO 15189等管理醫學實驗室能力的國際標準至關重要，以確保測試結果的準確性和可靠性。遵守這些法律規範對於市場擴張至關重要，尤其是在北美和歐洲等監管嚴格的地區。

哪些因素推動了自動免疫檢測市場的成長？

自動化免疫檢測設備市場的成長受到多種因素的推動，包括對診斷測試日益成長的需求、慢性病盛行率的上升以及提高測試效率和準確性的技術進步。感染疾病、癌症和糖尿病等疾病的日益普及推動了對更先進診斷工具的需求，而免疫檢測在其中發揮核心作用。個人化醫療需要準確的生物標記檢測，這進一步推動了對這些分析儀的需求。此外，自動化和人工智慧整合的進步正在提高實驗室的生產力，使醫療機構能夠在保持品質的同時處理更大的測試量。最後，在醫療基礎設施改善的推動下，新興市場診斷測試的擴展正在創造新的成長機會。

部分

最終用途（醫院、診斷實驗室、血庫、其他最終用途）、技術（螢光、化學冷光免疫檢測(CLIA)、酵素螢光免疫分析(ELFA)、酵素結合免疫吸附檢測法(ELISA)、免疫測量(RIA)、其他技術）

受訪公司範例

  • Artron Laboratories, Inc.
  • Awareness Technology, Inc.
  • Beckman Coulter（UK）Ltd.
  • Chengdu Empsun Medical Co., Ltd.
  • Diagnostic Automation/Cortez Diagnostics, Inc.
  • DiaSorin SpA
  • DRG Instruments GmbH
  • Erba Mannheim
  • Guangzhou Wondfo Biotech Co., Ltd
  • H&W Biotech Oy

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP16161

Global Automated Immunoassay Analyzers Market to Reach US$4.7 Billion by 2030

The global market for Automated Immunoassay Analyzers estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.7 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Chemiluminescence Immunoassay (CLIA) segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$993.3 Million While China is Forecast to Grow at 4.4% CAGR

The Automated Immunoassay Analyzers market in the U.S. is estimated at US$993.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$754.4 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Automated Immunoassay Analyzers Market - Key Trends & Drivers Summarized

Why Are Automated Immunoassay Analyzers Vital for Modern Diagnostics?

Automated immunoassay analyzers are revolutionizing diagnostic laboratories by enabling rapid, accurate, and high-throughput testing of biological samples. These instruments are crucial for detecting and quantifying specific proteins, hormones, and antibodies in blood or other fluids, making them essential in areas such as infectious disease diagnostics, oncology, and endocrinology. As healthcare systems prioritize early detection and personalized medicine, immunoassays have become a critical tool for diagnosing conditions such as HIV, cancer, and diabetes. The automation of these tests not only reduces the risk of human error but also increases the efficiency of diagnostic labs, enabling them to process large volumes of samples with minimal manual intervention. As the demand for diagnostic testing grows globally, automated immunoassay analyzers are becoming integral to modern healthcare.

How Are Technological Advancements Enhancing Automated Immunoassay Analyzers?

Technological innovations are significantly improving the capabilities and accuracy of automated immunoassay analyzers. Enhanced sensitivity and specificity, driven by advancements in detection methods such as chemiluminescence and fluorescence, are enabling earlier and more precise detection of biomarkers. Moreover, the integration of artificial intelligence (AI) and machine learning algorithms into these systems is optimizing the analysis and interpretation of complex data, helping clinicians make more informed diagnostic decisions. Automation is also extending to sample preparation and data management, further streamlining workflows and reducing the time required for results. As labs seek to improve turnaround times and operational efficiency, these technological advancements are driving the widespread adoption of automated immunoassay analyzers.

What Regulatory and Compliance Standards Govern the Use of Automated Immunoassay Analyzers?

Regulatory oversight is critical in the automated immunoassay analyzers market, as the accuracy and reliability of diagnostic tests directly impact patient care. Agencies such as the FDA and European Medicines Agency (EMA) enforce strict guidelines to ensure that immunoassay analyzers meet safety and efficacy standards before they are introduced to the market. These regulations require manufacturers to conduct rigorous clinical trials and maintain quality control during production. Additionally, compliance with international standards such as ISO 15189, which governs the competence of medical laboratories, is essential for labs using these systems to ensure that their test results are accurate and reliable. Adherence to these regulatory frameworks is necessary for market expansion, especially in highly regulated regions such as North America and Europe.

What Factors Are Driving the Growth of the Automated Immunoassay Analyzers Market?

The growth in the automated immunoassay analyzers market is driven by several factors, including the rising demand for diagnostic testing, the increasing prevalence of chronic diseases, and technological advancements that improve testing efficiency and accuracy. The growing incidence of infectious diseases and conditions such as cancer and diabetes is driving the need for more sophisticated diagnostic tools, where immunoassays play a central role. The trend toward personalized medicine, which requires precise biomarker detection, is further boosting demand for these analyzers. Additionally, advancements in automation and AI integration are enhancing lab productivity, allowing healthcare facilities to handle higher test volumes while maintaining quality. Finally, the expansion of diagnostic testing in emerging markets, fueled by improvements in healthcare infrastructure, is creating new opportunities for growth.

SCOPE OF STUDY:

The report analyzes the Automated Immunoassay Analyzers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Diagnostic Laboratories, Blood Bank, Other End-Uses); Technology (Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Other Technologies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Artron Laboratories, Inc.
  • Awareness Technology, Inc.
  • Beckman Coulter (UK) Ltd.
  • Chengdu Empsun Medical Co., Ltd.
  • Diagnostic Automation / Cortez Diagnostics, Inc.
  • DiaSorin SpA
  • DRG Instruments GmbH
  • Erba Mannheim
  • Guangzhou Wondfo Biotech Co., Ltd
  • H&W Biotech Oy

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Automated Immunoassay Analyzers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Driving Adoption of Immunoassay Analyzers
    • Technological Advancements in Automated Analyzers Boosting Market Growth
    • Growing Focus on Early Disease Detection Supporting Demand for Immunoassay Solutions
    • Rising Adoption in Clinical Laboratories for High-Throughput Testing Fuelling Growth
    • Expansion of Point-of-Care Diagnostics Enhancing Immunoassay Analyzer Market Demand
    • Increasing Healthcare Spending in Emerging Economies Boosting Market Opportunities
    • Rising Awareness of Personalized Medicine Supporting Use of Advanced Immunoassays
    • Growth of Infectious Disease Testing Requirements Supporting Analyzer Adoption
    • Development of Multiplex Testing Platforms Fuelling Innovations in Immunoassay Analyzers
    • Stringent Regulatory Standards for Laboratory Testing Supporting Automated Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Automated Immunoassay Analyzers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Automated Immunoassay Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Automated Immunoassay Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Immunofluorescence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay (CLIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chemiluminescence Immunoassay (CLIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chemiluminescence Immunoassay (CLIA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Radioimmunoassay (RIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Radioimmunoassay (RIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Radioimmunoassay (RIA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Blood Bank by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Blood Bank by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Blood Bank by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Automated Immunoassay Analyzers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Automated Immunoassay Analyzers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION